Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholinesterase Inhibitors”

99 trials

Showing 20 of 99 results

Large-scale testing (Phase 3)Study completedNCT01404169
What this trial is testing

A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Type Dementia
Eisai Limited 260
Large-scale testing (Phase 3)Study completedNCT02255799
What this trial is testing

Multicenter Evaluation of Memory Remediation After TBI With Donepezil

Who this might be right for
Traumatic Brain InjuryMemory Deficits
Baylor College of Medicine 75
Large-scale testing (Phase 3)Ended earlyNCT02080364
What this trial is testing

Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
vTv Therapeutics 880
Testing effectiveness (Phase 2)Study completedNCT01548638
What this trial is testing

Effect of Galantamine on Smoking Abstinence

Who this might be right for
Nicotine Addiction
University of Pennsylvania 13
Testing effectiveness (Phase 2)Study completedNCT02258152
What this trial is testing

SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)

Who this might be right for
Parkinson's Disease Dementia (PDD)
Biotie Therapies Inc. 82
Not applicableUnknownNCT02623764
What this trial is testing

EEG-cholinergic Index and Clinical Response to Treatment With Cholinesterase Inhibitors

Who this might be right for
Alzheimer´s Disease
Landspitali University Hospital 218
Post-approval studies (Phase 4)Study completedNCT00227994
What this trial is testing

Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke

Who this might be right for
Cerebrovascular Accident
University of Pittsburgh 40
Large-scale testing (Phase 3)Study completedNCT00623103
What this trial is testing

Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)

Who this might be right for
Parkinson's Disease Dementia
Novartis 583
Large-scale testing (Phase 3)Ended earlyNCT01014858
What this trial is testing

Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Newcastle-upon-Tyne Hospitals NHS Trust 64
Testing effectiveness (Phase 2)Looking for participantsNCT06041789
What this trial is testing

Effect of Acetylcholinesterase Inhibitors on Bone Metabolism

Who this might be right for
Osteoporosis
Duke University 45
Testing effectiveness (Phase 2)Study completedNCT00467389
What this trial is testing

Use of Donepezil for Treatment of Cocaine Dependence

Who this might be right for
Cocaine Abuse and Dependence
US Department of Veterans Affairs 12
Testing effectiveness (Phase 2)Study completedNCT01250977
What this trial is testing

Effect of Donepezil on Smoking

Who this might be right for
Smoking
Abramson Cancer Center at Penn Medicine 30
Not applicableStudy completedNCT00423228
What this trial is testing

Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease

Who this might be right for
Moderate Alzheimer's Disease
Debiopharm International SA 228
Early research (Phase 1)Study completedNCT01908010
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Who this might be right for
Alzheimer's Disease
AbbVie 20
Not applicableUnknownNCT02305589
What this trial is testing

The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium

Who this might be right for
Delirium
Konkuk University Medical Center 250
Testing effectiveness (Phase 2)UnknownNCT03038035
What this trial is testing

The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study

Who this might be right for
Alzheimer Disease
National University Hospital, Singapore 150
Testing effectiveness (Phase 2)WithdrawnNCT02246075
What this trial is testing

Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine

Who this might be right for
Alzheimer's DiseaseDementiaCognition
FORUM Pharmaceuticals Inc
Large-scale testing (Phase 3)Study completedNCT00277810
What this trial is testing

Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 250
Post-approval studies (Phase 4)Study completedNCT00622713
What this trial is testing

A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)

Who this might be right for
Alzheimer's Disease
Novartis 228
Early research (Phase 1)Study completedNCT03063515
What this trial is testing

AchE Inhibitor and Insulin

Who this might be right for
Diabetes Mellitus
University of Miami 12
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation